CPT 95911: Nerve Conduction Studies, 9–10 Tests
Medicare pays $152 and commercial payers pay $256 on average nationally for this procedure.
CPT code 95911 describes a diagnostic nerve conduction study procedure involving nine to ten nerve conduction studies to evaluate motor and sensory nerve electrical conduction; the service is a neurodiagnostic test typically performed in an ambulatory clinic or outpatient neurodiagnostic lab setting to assess peripheral nerve function for conditions such as entrapment neuropathies.
For related coverage guidance, see recent payer policy updates: Lumbar Microdiscectomy, Artificial Cervical Intervertebral Disc, Lumbar Decompression.
Customize your policy alerts
Sign up for cpt 95911 policy alerts
Get alerted when payer policies referencing 95911 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Commercial averages sit well above Medicare: Blue Cross Blue Shield, Cigna, Aetna, UnitedHealth Group and BUCA all have mean commercial rates notably higher than Medicare’s mean of $152.20; BUCA’s mean of $256.00 in particular is roughly $103.80 above Medicare, highlighting a wide gulf between Medicare payment levels and commercial average contracting for CPT 95911. Dispersion across payers varies: range (P75–P25) calculations show Blue Cross Blue Shield at $97.70, UnitedHealth Group at $162.30, Cigna at $163.60, Aetna at $132.00, and BUCA at $121.90. Cigna and UnitedHealth Group display the widest interquartile spreads (~$163), indicating greater variability in commercial reimbursed rates, while Blue Cross Blue Shield is the tightest at $97.70, suggesting comparatively concentrated commercial pricing.